By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
IndebtaIndebta
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Notification Show More
Aa
IndebtaIndebta
Aa
  • Banking
  • Credit Cards
  • Loans
  • Dept Management
  • Mortgage
  • Markets
  • Investing
  • Small Business
  • Videos
  • Home
  • News
  • Banking
  • Credit Cards
  • Loans
  • Mortgage
  • Investing
  • Markets
    • Stocks
    • Commodities
    • Crypto
    • Forex
  • Videos
  • More
    • Finance
    • Dept Management
    • Small Business
Follow US
Indebta > Investing > Chewy, Pfizer, Raytheon, Toro Make New 52-Week Lows List
Investing

Chewy, Pfizer, Raytheon, Toro Make New 52-Week Lows List

News Room
Last updated: 2023/09/16 at 1:44 PM
By News Room
Share
4 Min Read
SHARE

It’s the heaviness of the selling volume in these big market capitalization stocks that stands out. These New York Stock Exchange listed names don’t get half the coverage in the financial media as some tech and social media favorites. It would be easy to miss how far down some former leaders have travelled.

Price chart analysis:

Chewy is an online retailer of mostly pet foods and, along with a lower-than-expected consumer sentiment metric this week, also suffered from the displeasure of CNBC “analyst” Jim Cramer, who this week bad-mouthed the company on the air. The daily price chart looks like this now:

From the early February peak of $52, Chewy has trended steadily lower to its current price of $20.15, a 59% drop in less than a year. Note the big red selling bars (below the price chart) in late August and in September. It’s probably safe to say that the stock is no longer a favorite of the on-line retailer investor.

Pfizer
PFE
is a major biopharmaceutical company with operations around the globe. One of its products (along with Moderna) is Covid booster shots. Market capitalization comes to $19253 billion.

In mid-July, JP Morgan “reiterated” its “neutral” rating of the stock with a price target of $45 to $41. Credit Suisse in late June downgraded Pfizer from “outperform” to “neutral” with a price target of $47 to $40.

The daily price chart is here:

It’s declined from $49 in January to $34 in September — for those who bought early in the year that’s a loss of 30%. Last week’s selling picked up as indicated by the big red volume bar beneath the price chart. The relative strength indicator (RSI) suggests a positive divergence to price movement.

Raytheon is a major aerospace and defense contractor with a market capitalization of $111.45 billion. The company is reported to have ended a billion-dollar agreement with Saudi Arabian individuals over concerns of their possible connections with Russian and Chinese operatives.

The price drop is from $106 in January to September’s $74 — a plunge of 30%. The 50-day moving average (the blue line) crossed below the 200-day moving average (the red line) as the stock gapped down in July.

Take a look at the Raytheon weekly price chart:

Note how — in the red-circled area — the price is now below the 200-week moving average, a significant factor likely to be picked up by Wall Street algorithms and the humans who write the code.

The Toro
TTC
Company manufactures tools and sells them under brand names like Ditch Witch, Exmark and Spartan Mowers. With corporate headquarters in Bloomington, Minnesota, the company has a market capitalization of $9.05 billion. Less than expected earnings reported in September have led to the dumping of shares:

A sharp price chart analyst might have seen issues coming back in early June when the 50-day moving average crossed below the 200-day moving average.

Read the full article here

News Room September 16, 2023 September 16, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Finance Weekly Newsletter

Join now for the latest news, tips, and analysis about personal finance, credit cards, dept management, and many more from our experts.
Join Now
Why bomb Sokoto? Trump’s strikes baffle Nigerians

It was around 10pm on Christmas Day when residents of the mainly…

Pressure grows on Target as activist investor builds stake

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

Mosque bombing in Alawite district in Syria leaves at least 8 dead

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects…

EU will lose ‘race to the bottom’ on regulation, says competition chief

Stay informed with free updatesSimply sign up to the EU business regulation…

“It’s a very bad bet to bet against US companies”: Analyst

Watch full video on YouTube

- Advertisement -
Ad imageAd image

You Might Also Like

Investing

Nursing Home Stocks Could Suffer from this Medicaid Spending Remedy

By News Room
Investing

Bitcoin Drops Below $90,000 Again. What Could Move It Next.

By News Room
Investing

These Stocks Are Moving the Most Today: Marvell, Nvidia, Broadcom, GM, Tesla, MongoDB, Burlington, and More

By News Room
Investing

Nvidia Stock Falls as Marvell Earnings Compound AI Gloom. The Rising Risks for Chips.

By News Room
Investing

This analyst says Tesla deliveries will be 16% below expectations. Musk is part of the problem.

By News Room
Investing

BP CEO was awarded no bonus pay from oil giant’s financial performance

By News Room
Investing

Shares of Starlink’s European competitor have tripled. CEO says it can do the job in Ukraine.

By News Room
Investing

GE Vernova Stock Rises as Analyst Flips to Upgrade After Rating Cut

By News Room
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Press Release
  • Contact
  • Advertisement
More Info
  • Newsletter
  • Market Data
  • Credit Cards
  • Videos

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions
Join Community

2023 © Indepta.com. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?